Table 1 Applications of flavivirus capsid proteins
Proteins | Viruses | Virus strains | Application types | References |
|---|---|---|---|---|
EDIII and C | DENV | Hawaii (DENV-1) New Guinea C (DENV-2) H-87 (DENV-3) H241 (DENV-4) DENV-2 A15 DENV-2 SB8553/S16803 | Subunit vaccine | |
DENV-1 Jamaica (AF42564) DENV-2 SB8553 DENV-3 (FJ882576) DENV-4 (AF326573) | Vaccine | [125] | ||
DENV-2 A-15 strain DENV-2 SB8553 DENV-2 Jamaica | Vaccine | [126] | ||
C | Hawaii (DENV-1) New Guinea C (DENV-2) H-87 (DENV-3) H241 (DENV-4) DENV-2 SB8553 | Vaccine | [127] | |
Four serotypes | Antiviral agent | [128] | ||
C | JEV | Wild-type and 9798A mutant of JEV AT31 | Antiviral agent | [92] |
Wild-type and L17A/CSmt JEVs | Pathogenesis of JEV infection | [117] | ||
C | WNV | WNV NY99 | Live vaccine candidates | [110] |
C | TMUV | DTMUV WR strain | DNA vaccine | [129] |
CQW1 strain | Target therapeutic | [130] | ||
C-prM-E | ZIKV | PRVABC59 | Virus-like particle vaccines | [131] |
C | FSS13025 strain | Live-attenuated vaccine | [132] | |
VSV-C | PRVABC59 strain | Vesicular stomatitis virus (VSV)-based vaccine | [102] |